Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

60
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
60
Tissue Transplantation01:24

Tissue Transplantation

519
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
519
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

32
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
32

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Escalation Strategies in Cardiogenic Shock: From Early Recognition to Advanced Support.

Cardiology clinics·2026
Same author

The Association Between the Risk Analysis Index of Frailty and Patient Safety Indicators: A Single-System Cohort Study.

The Journal of surgical research·2026
Same author

Erratum to 2025 American Association for Thoracic Surgery (AATS) Expert Consensus Document: Surgical management of acute myocardial infarction and associated complications: The Journal of Thoracic and Cardiovascular Surgery, Volume 170, Issue 5, 2025, Pages 1327-1344.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Incidence and clinical outcomes of extended duration support in patients with Impella 5.5 - Analysis from the LOQI Registry.

JHLT open·2026
Same author

Long-Term Outcomes of Native Heart Survival in Cardiogenic Shock Patients Treated With Impella 5.5.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Long-term outcomes of postoperative atrial fibrillation after cardiac surgery: Results from 19,000 patients.

The Journal of thoracic and cardiovascular surgery·2026

相关实验视频

Updated: Sep 9, 2025

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
06:40

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death

Published on: June 6, 2025

261

中心经验与捐献后更大的存活率有关

Brian E Woolley1, Yeahwa Hong2, Umar Nasim1

  • 1Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
|August 28, 2025
PubMed
概括

在循环死亡 (DCD) 心脏移植后的捐赠中,更高的中心经验提高了1年的生存率. 在20个DCD病例的生存效益高原,强调了机构DCD专业知识的价值.

关键词:
在循环死亡后的捐赠心脏移植心脏使用率移植中心的数量移植结果

更多相关视频

Pre-clinical Model of Cardiac Donation after Circulatory Death
06:26

Pre-clinical Model of Cardiac Donation after Circulatory Death

Published on: August 2, 2019

8.0K
Large-Animal Model of Donation after Circulatory Death and Normothermic Regional Perfusion for Cardiac Assessment
07:49

Large-Animal Model of Donation after Circulatory Death and Normothermic Regional Perfusion for Cardiac Assessment

Published on: May 10, 2022

1.7K

相关实验视频

Last Updated: Sep 9, 2025

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
06:40

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death

Published on: June 6, 2025

261
Pre-clinical Model of Cardiac Donation after Circulatory Death
06:26

Pre-clinical Model of Cardiac Donation after Circulatory Death

Published on: August 2, 2019

8.0K
Large-Animal Model of Donation after Circulatory Death and Normothermic Regional Perfusion for Cardiac Assessment
07:49

Large-Animal Model of Donation after Circulatory Death and Normothermic Regional Perfusion for Cardiac Assessment

Published on: May 10, 2022

1.7K

科学领域:

  • 移植手术
  • 器官捐赠
  • 心血管医学

背景情况:

  • 中心体积与固体器官移植的更好结果有关.
  • 中心经验对循环死亡 (DCD) 心脏移植后的捐赠的影响尚不清楚.
  • 这项研究研究了DCD中心的累积经验如何影响移植后的生存.

研究的目的:

  • 评估累积DCD中心经验与移植后1年存活率之间的关联.
  • 确定更高的DCD移植量是否与改善的患者结果相关.
  • 研究DCD心脏移植中的体积-结果关系.

主要方法:

  • 使用成人DCD心脏移植的UNOS注册表 (1/1/2019-12/31/2023).
  • 将中心分为低 (≤10),中等 (11-24) 和高 (≥25) 的累积DCD体积组.
  • 使用受限立方线 (RCS) 模型分析体积-结果关系和1年存活率.

主要成果:

  • 在59个中心分析了1,114例DCD心脏移植.
  • 低DCD体量中心的1年生存率 (89. 0%) 与高体量中心 (92. 9%) 相比显著降低.
  • 在大约20例DCD病例后,生存率稳定;NRP和DPP方法显示的生存率相似.

结论:

  • 增加累积的DCD中心经验与更好的1年移植后存活率独立相关.
  • 机构的DCD经验至关重要,生存效益在大约20个病例后稳定.
  • 这些发现支持扩大DCD心脏移植,同时强调需要专门中心的经验.